Market Overview:
The global transdermal skin patch market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in transdermal patches. Based on type, the fentanyl transdermal skin patch segment is expected to account for the largest share of the global transdermal skin patch market in 2018. This segment is also projected to grow at a higher CAGR during the forecast period as compared to other segments. Fentanyl is a potent opioid analgesic that is used for relieving severe pain in patients with cancer or post-operative pain. It has been found that fentanyl patches are more effective than oral morphine for controlling moderate-to-severe cancer pain and improve patient’s quality of life significantly when compared with placebo patches.
Product Definition:
A transdermal skin patch is a medicated adhesive patch that is placed on the skin to deliver a dose of medication through the skin and into the bloodstream. The patch is usually worn for 24 hours, although some patches are only worn for 12 hours. The most common type of medication delivered by transdermal patches are opioids such as fentanyl, which are used to treat pain. Transdermal patches can also be used to deliver nicotine, which helps people quit smoking, and hormone replacement therapy medications such as estrogen and testosterone.
Fentanyl Transdermal Skin Patch:
Fentanyl Transdermal Skin Patch is a new form of drug delivery technology which involves the use of transdermal patches containing drugs. These patches are used to deliver medications directly into the skin without first having to ingest it. The patch works by allowing drugs to pass through the skin and into the bloodstream, thereby delivering it directly where it is needed most - in contrast to traditional methods such as oral ingestion or intravenous injection which passes through stomach and liver first before reaching other organs.
Nicotine Transdermal Skin Patch:
Nicotine Transdermal Skin Patch is a transdermal patch that allows the delivery of nicotine through the skin. It works by allowing a small amount of nicotine to be absorbed into the bloodstream via the skin. The Nicotine Transdermal Skin Patch was approved bythe U.S Food and Drug Administration (FDA) in 2016 for treating smoking cessation, which is also known as Quitting Smoking or NRTs.
Application Insights:
The other application segment covered in the study includes treating opioid dependence, anxiety disorders and post-surgical pain. The relief of severe pain segment dominated the overall market in 2017 owing to high usage rates of transdermal skin patches for this purpose among patients diagnosed with chronic pain.
According to a study published by NCBI, approximately 60% of patients suffering from chronic non-cancer Pain have been found to be actively seeking medical care and treatment options; these numbers are expected to increase over the coming years as more people are becoming aware about various treatments available for them. This factor is anticipated to fuel product demand in near future.
The stop smoking cigarettes application segment is also expected register notable gains during the forecast period owingto rising awareness campaigns against this hazardous activity among youth population, coupled with increasing government regulations aimed at curbing tobacco use across various regions worldwide.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of companies and high adoption rate for transdermal products. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by manufacturers and rising product launches. Moreover, growing opioid epidemic in North America is driving people towards alternative ways of pain management, thereby boosting regional growth.
Asia Pacific also captured a significant share in terms of revenue generation as well as adoption rates for transdermal skin patches across various applications. This can be attributed to growing awareness about these patches among patients suffering from chronic diseases such as diabetes, hypertension, epilepsy etc., especially in India & China markets. Increasing government initiatives aimed at reducing tobacco consumption are also expected to fuel regional growth over the forecast period (2018-2030).
Growth Factors:
- Increasing demand for better and convenient modes of drug delivery
- Rising prevalence of chronic diseases that require long-term treatment
- Growing awareness about the benefits of transdermal skin patches among consumers and healthcare professionals
- Technological advancements in the manufacturing of transdermal skin patches that improve their efficacy and safety profile
- Expansion of the product portfolio by manufacturers to cater to a wider range of therapeutic indications
Scope Of The Report
Report Attributes
Report Details
Report Title
Transdermal Skin Patch Market Research Report
By Type
Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch, Clonidine Transdermal Skin Patch, Buprenorphine Transdermal Skin Patch
By Application
Relieve Severe Pain, Stop Smoking Cigarettes, Treat An Overactive Bladder, Others
By Companies
Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Luye Pharma Group Ltd., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Transdermal Skin Patch Market Report Segments:
The global Transdermal Skin Patch market is segmented on the basis of:
Types
Fentanyl Transdermal Skin Patch, Nicotine Transdermal Skin Patch, Clonidine Transdermal Skin Patch, Buprenorphine Transdermal Skin Patch
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Relieve Severe Pain, Stop Smoking Cigarettes, Treat An Overactive Bladder, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Hisamitsu Pharmaceutical
- Novartis
- Johnson & Johnson
- Teikoku Pharma
- Mylan
- Actavis
- Mundipharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
- Luye Pharma Group Ltd.
- Purdue Pharma L.P.
- Teva Pharmaceutical Industries Ltd.
Highlights of The Transdermal Skin Patch Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fentanyl Transdermal Skin Patch
- Nicotine Transdermal Skin Patch
- Clonidine Transdermal Skin Patch
- Buprenorphine Transdermal Skin Patch
- By Application:
- Relieve Severe Pain
- Stop Smoking Cigarettes
- Treat An Overactive Bladder
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transdermal Skin Patch Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A transdermal skin patch is a type of medication that is applied to the skin. It releases a drug into the body through the skin.
Some of the major players in the transdermal skin patch market are Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Luye Pharma Group Ltd., Purdue Pharma L.P., Teva Pharmaceutical Industries Ltd..
The transdermal skin patch market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transdermal Skin Patch Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transdermal Skin Patch Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transdermal Skin Patch Market - Supply Chain
4.5. Global Transdermal Skin Patch Market Forecast
4.5.1. Transdermal Skin Patch Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transdermal Skin Patch Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transdermal Skin Patch Market Absolute $ Opportunity
5. Global Transdermal Skin Patch Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transdermal Skin Patch Market Size and Volume Forecast by Type
5.3.1. Fentanyl Transdermal Skin Patch
5.3.2. Nicotine Transdermal Skin Patch
5.3.3. Clonidine Transdermal Skin Patch
5.3.4. Buprenorphine Transdermal Skin Patch
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transdermal Skin Patch Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transdermal Skin Patch Market Size and Volume Forecast by Application
6.3.1. Relieve Severe Pain
6.3.2. Stop Smoking Cigarettes
6.3.3. Treat An Overactive Bladder
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transdermal Skin Patch Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transdermal Skin Patch Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transdermal Skin Patch Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transdermal Skin Patch Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transdermal Skin Patch Demand Share Forecast, 2019-2026
9. North America Transdermal Skin Patch Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transdermal Skin Patch Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transdermal Skin Patch Market Size and Volume Forecast by Application
9.4.1. Relieve Severe Pain
9.4.2. Stop Smoking Cigarettes
9.4.3. Treat An Overactive Bladder
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transdermal Skin Patch Market Size and Volume Forecast by Type
9.7.1. Fentanyl Transdermal Skin Patch
9.7.2. Nicotine Transdermal Skin Patch
9.7.3. Clonidine Transdermal Skin Patch
9.7.4. Buprenorphine Transdermal Skin Patch
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transdermal Skin Patch Demand Share Forecast, 2019-2026
10. Latin America Transdermal Skin Patch Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transdermal Skin Patch Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transdermal Skin Patch Market Size and Volume Forecast by Application
10.4.1. Relieve Severe Pain
10.4.2. Stop Smoking Cigarettes
10.4.3. Treat An Overactive Bladder
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transdermal Skin Patch Market Size and Volume Forecast by Type
10.7.1. Fentanyl Transdermal Skin Patch
10.7.2. Nicotine Transdermal Skin Patch
10.7.3. Clonidine Transdermal Skin Patch
10.7.4. Buprenorphine Transdermal Skin Patch
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transdermal Skin Patch Demand Share Forecast, 2019-2026
11. Europe Transdermal Skin Patch Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transdermal Skin Patch Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transdermal Skin Patch Market Size and Volume Forecast by Application
11.4.1. Relieve Severe Pain
11.4.2. Stop Smoking Cigarettes
11.4.3. Treat An Overactive Bladder
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transdermal Skin Patch Market Size and Volume Forecast by Type
11.7.1. Fentanyl Transdermal Skin Patch
11.7.2. Nicotine Transdermal Skin Patch
11.7.3. Clonidine Transdermal Skin Patch
11.7.4. Buprenorphine Transdermal Skin Patch
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transdermal Skin Patch Demand Share, 2019-2026
12. Asia Pacific Transdermal Skin Patch Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transdermal Skin Patch Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transdermal Skin Patch Market Size and Volume Forecast by Application
12.4.1. Relieve Severe Pain
12.4.2. Stop Smoking Cigarettes
12.4.3. Treat An Overactive Bladder
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transdermal Skin Patch Market Size and Volume Forecast by Type
12.7.1. Fentanyl Transdermal Skin Patch
12.7.2. Nicotine Transdermal Skin Patch
12.7.3. Clonidine Transdermal Skin Patch
12.7.4. Buprenorphine Transdermal Skin Patch
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transdermal Skin Patch Demand Share, 2019-2026
13. Middle East & Africa Transdermal Skin Patch Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transdermal Skin Patch Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transdermal Skin Patch Market Size and Volume Forecast by Application
13.4.1. Relieve Severe Pain
13.4.2. Stop Smoking Cigarettes
13.4.3. Treat An Overactive Bladder
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transdermal Skin Patch Market Size and Volume Forecast by Type
13.7.1. Fentanyl Transdermal Skin Patch
13.7.2. Nicotine Transdermal Skin Patch
13.7.3. Clonidine Transdermal Skin Patch
13.7.4. Buprenorphine Transdermal Skin Patch
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transdermal Skin Patch Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transdermal Skin Patch Market: Market Share Analysis
14.2. Transdermal Skin Patch Distributors and Customers
14.3. Transdermal Skin Patch Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Hisamitsu Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Novartis
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Johnson & Johnson
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teikoku Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mylan
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Actavis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mundipharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Henan Lingrui Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Changzhou Siyao
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Rfl Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Luye Pharma Group Ltd.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Purdue Pharma L.P.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Teva Pharmaceutical Industries Ltd.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
